by Elena Iemma | Apr 3, 2024 | Events
For the first time, EpiVax is hosting two back-to-back seminars in one of our favorite cities: Tokyo, Japan. Join us on Thursday for the Westin Immunogenicity Seminar, on Friday for the Computational Vaccinology Symposium, or both! As always, participation is free of...
by Elena Iemma | Dec 20, 2023 | News
PROVIDENCE, RI, December 20, 2023 /PRNewswire/ — EpiVax, Inc. (“EpiVax”), an internationally recognized leader in the field of immunogenicity, today announced that Eisai Co. Ltd. (“Eisai”) has licensed EpiVax’s ISPRI toolkit for immunogenicity risk assessment of...
by Elena Iemma | Mar 3, 2023 | Events
The EpiVax team had a great time in Tokyo hosting the 15th annual Westin Immunogenicity Seminar! Thank you to all who were in attendance. See pictures from the event below. Interested in attending the Westin Immunogenicity Seminar in 2024? Sign up here! The 15th...
by Adam | Oct 23, 2019 | News
Announced today, Chugai Pharmaceutical Co., Ltd. (“Chugai”), a member of the Roche Group, will extend the company’s licensed access to the Immunogenicity Screening and Protein Reengineering Interface (ISPRI) toolkit developed by EpiVax, Inc....
